不同放疗模式对局部晚期喉癌患者剂量学参数及肿瘤标志物水平的影响  

Impact of Different Radiotherapy Modes on Dosimetric Parameters and Tumor Marker Levels of Patients with Locally Advanced Laryngeal Cancer

在线阅读下载全文

作  者:梁宁 韩文华 王伟志 LIANG Ning;HAN Wenhua;WANG Weizhi(Radiology Department,Hebi Coal Industry(Group)Co.,Ltd.General Hospital,Hebi 458000,China;Oncology Surgery Department,Hebi Coal Industry(Group)Co.,Ltd.General Hospital,Hebi 458000,China;Radiotherapy Department,Hebi Coal Industry(Group)Co.,Ltd.General Hospital,Hebi 458000,China)

机构地区:[1]鹤壁煤业(集团)有限责任公司总医院放射科,河南鹤壁458000 [2]鹤壁煤业(集团)有限责任公司总医院肿瘤外科,河南鹤壁458000 [3]鹤壁煤业(集团)有限责任公司总医院放疗科,河南鹤壁458000

出  处:《临床医学工程》2024年第12期1461-1462,共2页Clinical Medicine & Engineering

摘  要:目的对比容积旋转调强放疗(VMAT)、螺旋断层放疗(HT)治疗局部晚期喉癌的效果。方法82例局部晚期喉癌患者随机分为参照组(VMAT治疗)和研究组(HT治疗),比较两组的剂量学参数和肿瘤标志物水平。结果研究组GTV与PTV的D2、D50、HI低于参照组,CI高于参照组,治疗后的血清CA125、CA19-9、CEA水平低于参照组(P<0.05)。结论与VMAT相比,HT治疗局部晚期喉癌患者GTV与PTV放疗药物剂量的适形度、均匀性更好,使用剂量更少,肿瘤标志物水平更低。Objective To compare the effects of volumetric modulated arc therapy(VMAT)and helical tomotherapy(HT)in the treatment of locally advanced laryngeal cancer.Methods 82 patients with locally advanced laryngeal cancer were randomly divided into the reference group(VMAT treatment)and the study group(HT treatment).The dosimetric parameters and tumor marker levels of the two groups were compared.Results The D_2,D_(50)and HI of GTV and PTV in the study group were lower than those in the reference group,the CI were higher than those in the reference group,and the serum CA125,CA19-9 and CEA levels after treatment were lower than those in the reference group(P<0.05).Conclusions Compared with VMAT,HT in the treatment of patients with locally advanced laryngeal cancer has better conformal and uniformity of GTV and PTV radiotherapy drug dose,lower use of dose,and lower levels of tumor markers.

关 键 词:局部晚期喉癌 螺旋断层放疗 容积旋转调强放疗 剂量学参数 

分 类 号:R730.55[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象